GT Biopharma (GTBP) had the highest return between 2010 and 2013 by a US stock in the Nasdaq Composite (IXIC), returning 52,699,934%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2010-2013	52,699,934%
Nutex Health (NUTX)	2010-2013	749,900.2%
NextTrip (NTRP)	2010-2013	493,233.33%
BioLineRx (BLRX)	2010-2013	27,132.64%
Xpel (XPEL)	2010-2013	3,273.68%
Nova Lifestyle I (NVFY)	2010-2013	2,906.67%
BOS Better Online Solutions (BOSC)	2010-2013	2,578.88%
Natural Health Trend (NHTC)	2010-2013	2,154.75%
ACADIA Pharmaceuticals (ACAD)	2010-2013	1,793.18%
Jazz Pharmaceuticals (JAZZ)	2010-2013	1,470.22%
Nexstar Broadcasting (NXST)	2010-2013	1,301.91%
DarioHealth (DRIO)	2010-2013	1,250%
Where Food Comes From (WFCF)	2010-2013	1,233.36%
Fonar (FONR)	2010-2013	1,209.26%
N2OFF (NITO)	2010-2013	1,150%
Barfresh Food (BRFH)	2010-2013	1,140%
MiMedx (MDXG)	2010-2013	1,097.26%
Patrick Industries (PATK)	2010-2013	1,076.07%
Regeneron Pharmaceuticals (REGN)	2010-2013	1,035.48%
Melco Resorts & Entertainment (MLCO)	2010-2013	1,030.24%
Sinclair Broadcast (SBGI)	2010-2013	1,027.25%
Acadia Healthcare (ACHC)	2010-2013	956.47%
Sunshine Biopharma (SBFM)	2010-2013	941.67%
Puma Biotechnology (PBYI)	2010-2013	935.3%
Astronics (ATRO)	2010-2013	925.68%